Botulinum toxin follow-up clinics: training implications.
Larner
A
A
D018726:Anti-Dyskinesia Agents / Q000008:administration & dosage*; D001905:Botulinum Toxins / Q000008:administration & dosage*; D004739:England; D006801:Humans; D008485:Medical Audit; D009462:Neurology / Q000193:education*
D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins